The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study

• Main Authors: Ping-Chih Hsu (Author), Chun-Yao Huang (Author), Chin-Chou Wang (Author), Scott Chih-Hsi Kuo (Author), Chia-Hsun Chu (Author), Pi-Hung Tung (Author), Allen Chung-Cheng Huang (Author), Chih-Liang Wang (Author), Li-Chung Chiu (Author), Yueh-Fu Fang (Author), Cheng-Ta Yang (Author)
• Format: Book
• Published: MDPI AG, 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The efficacy of afatinib in combination with bevacizumab in untreated advanced epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma is currently unclear. We sought to investigate the efficacy of this combination through a multicenter observational analysis. Data for 57 patients with a...